Long term outcomes in myelin oligodendrocyte glycoprotein-IgG (MOG-IgG) associated disorders

被引：0
|
作者：
Lopez-Chiriboga, A. S. [1 ]
Buciuc, M. [1 ]
Sechi, E. [1 ]
Pittock, S. J. [1 ,2 ]
Chen, J. J. [1 ,3 ]
Weinshenker, B. G. [1 ]
Dubey, D. [1 ,2 ]
Amy, K. [1 ]
Tillema, J. -M. [1 ]
Flanagan, E. [1 ,2 ]
机构：
[1] Mayo Clin, Neurol, Rochester, MN USA
[2] Mayo Clin, Dept Lab Med, Rochester, MN USA
[3] Mayo Clin, Dept Ophthalmol, Rochester, MN USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P728
引用
收藏
页码：366 / 366
页数：1
相关论文
共 50 条
  • [1] Long term outcomes in Myelin Oligodendrocyte Glycoprotein-IgG (MOG-IgG) Associated Disorders
    Lopez-Chiriboga, Sebastian
    Buciuc, Marina
    Sechi, Elia
    Pittock, Sean
    Chen, John
    Weinshenker, Brian
    Dubey, Divyanshu
    Kunchok, Amy
    Tillema, Jan-Mendelt
    Flanagan, Eoin
    NEUROLOGY, 2020, 94 (15)
  • [2] Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Perineuritis
    Lopez-Chiriboga, A. Sebastian
    Van Stavern, Gregory
    Flanagan, Eoin P.
    Pittock, Sean J.
    Fryer, Jim
    Bhatti, M. Tariq
    Chen, John J.
    NEURO-OPHTHALMOLOGY, 2020, 44 (01) : 1 - 4
  • [3] Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS
    Lopez-Chiriboga, Sebastian
    Pittock, Sean J.
    Weinshenker, Brian G.
    Chen, John J.
    Flanagan, Eoin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 35 : 34 - 35
  • [4] Cognitive Outcomes in Myelin Oligodendrocyte Glycoprotein-IgG Associated Disease Compared to Multiple Sclerosis
    Galvani, Eileen
    Cohen, Jeffrey A.
    Martin, John T.
    Nakamura, Kunio
    Kunchok, Amy
    Galioto, Rachel
    BRAIN AND BEHAVIOR, 2025, 15 (03):
  • [5] Response to correspondence: Testing for myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in typical MS
    Breza, Marianthi
    Koutsis, Georgios
    Tzartos, John S.
    Velonakis, Georgios
    Evangelopoulos, Maria Eleftheria
    Tzanetakos, Dimitrios
    Karagiorgou, Katerina
    Angelopoulou, Georgia
    Kasselimis, Dimitrios
    Potagas, Constantin
    Anagnostouli, Maria
    Stefanis, Leonidas
    Kilidireas, Constantinos
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 35 : 156 - 157
  • [6] Cross-reactivity of MOG-IgG against Butyrophilins in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
    Nishiyama, Shuhei
    Mikami, Takahisa
    Bilodeau, Phillippe-Antoine
    Anderson, Monique
    Bobrowski-Khoury, Natasha
    Drosu, Natalia
    Levy, Michael
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 239 - 239
  • [7] Lesion Evolution on MRI in Myelitis Associated with MS, Aquaporin-4-IgG and Myelin Oligodendrocyte Glycoprotein-IgG
    Sechi, Elia
    Krecke, Karl
    Buciuc, Marina
    Pittock, Sean J.
    Weinshenker, Brian G.
    Lopez-Chiriboga, A. Sebastian
    Zalewski, Nicholas
    Flanagan, Eoin P.
    NEUROLOGY, 2020, 94 (15)
  • [8] Long-term outcomes in MOG-IgG plus Optic Neuritis
    da Costa, B. K.
    dos Passos, G. R.
    Sommer, R. C.
    Becker, J.
    Sato, D. K.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 754 - 755
  • [9] Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series
    Lambe, Jeffrey
    McGinley, Marisa P.
    Moss, Brandon P.
    Mao-Draayer, Yang
    Kassa, Roman
    Ciotti, John R.
    Mariotto, Sara
    Kunchok, Amy
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 370
  • [10] Recent developments in MOG-IgG associated neurological disorders
    Hegen, Harald
    Reindl, Markus
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
12345